Tumor Strategy and Operations Lead – Oncology Commercial Strategy at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Oncology, BiotechnologyIndustries

Requirements

Bachelor’s degree required; advanced degree (MBA, PharmD, PhD, MD) strongly preferred
Minimum 8+ years of experience in pharmaceutical/biotech industry, with significant experience in oncology commercial strategy, marketing, or operations
Proven track record of developing and executing tumor-specific strategies (e.g., Lung, Melanoma, GU, Hematology, Breast, GI)
Experience leading cross-functional teams and managing direct reports
Strong financial acumen and experience with resource allocation, forecasting, and operating expense management
Demonstrated ability to leverage data and analytics (BI&A, RWD, HEOR) for strategic decision-making
Experience with congress planning, launch operations, and customer model strategy
Strategic Thinking: Ability to develop and execute comprehensive tumor strategies

Responsibilities

Develop and manage short- and mid-range tumor strategies and operational plans in alignment with overall franchise and portfolio objectives
Identify and capitalize on business opportunities within assigned tumor areas, ensuring strategic and operational planning supports growth and innovation
Streamline operational processes to enhance team efficiency, effectiveness, and best practice sharing across the Oncology Commercial Strategy team
Align HCP tactics and brand initiatives with tumor strategy to drive performance and deliver on commercial priorities
Oversee POA (Plan of Action) strategy, agenda, and coordination with sales operations, training, and brand teams for assigned tumors
Deliver tumor performance reviews and insights to senior management, supporting earnings calls and topline forecasts
Manage operating expenses, resource allocation, and analytics reporting (weekly, monthly, quarterly) for assigned tumor areas, ensuring alignment with Business Insights & Analytics (BI&A)
Facilitate coordination across commercial, medical, and launch teams for tumor-specific initiatives and congresses
Lead customer model strategy, including analysis of tumor synergies, account management optimization, and leveraging RWD and HEOR data across field teams
Collaborate with leadership to define and implement cultural initiatives that promote diversity, inclusion, and a collaborative work environment
Partner with medical, finance, market research, global marketing, and other S&O leads to ensure alignment with key portfolio initiatives and priorities
Provide strategic insight and direction as a member of the Oncology Commercial Strategy Leadership Team

Skills

Oncology Strategy

Commercial Strategy

Tumor Strategy

Operational Excellence

Strategic Planning

Team Management

Cross-Functional Alignment

Business Development

Process Optimization

HCP Tactics

Brand Initiatives

Franchise Management

Portfolio Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free